Fundraising Fox
/Companies
Sign in

IO Biotech

10 known investors

Find your way into IO Biotech

Sign up to find every way you can get introduced to IO Biotech

  • Your email: who you already know at IO Biotech, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the IO Biotech team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

IOBiotech appears to be a biotech company focused on oncology, with a founder who has extensive experience in cancer drug development and clinical advancement from roles at Roche, Eli Lilly, and leading academic cancer centers.

BiotechMedical Devices

Founders & leadership

DD
Dr. Dhingra

Investors · 10

EIR Ventureslisted by EIR VenturesStockholm
Kurma Partnerslisted by Kurma PartnersParis · $162K – $10.8M

How we know: Kurma Partners's portfolio page · funding news · the VCSheet dataset · Not right? Tell us

Pivotal Life Scienceslisted by Pivotal Life SciencesSan Francisco

How we know: Pivotal Life Sciences's portfolio page · Not right? Tell us

RA Capitallisted by RA CapitalBoston

How we know: RA Capital's portfolio page · Not right? Tell us

Samsara BioCapitallisted by Samsara BioCapitalMenlo Park

How we know: Samsara BioCapital's portfolio page · Not right? Tell us

Sunstone Capitallisted by Sunstone CapitalFrederiksberg

How we know: Sunstone Capital's portfolio page · the VCSheet dataset · Not right? Tell us

Vivo Capitallisted by Vivo CapitalPalo Alto · $10M – $50M

How we know: Vivo Capital's portfolio page · a partner's Signal profile · Not right? Tell us

European Investment BankreportedLuxembourg

How we know: funding news · press coverage · Not right? Tell us

HBM Healthcare InvestmentsreportedZug

How we know: funding news · Not right? Tell us

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

IO Biotech Completes Oversubscribed EUR 127 Million Series B Financing to Accelerate Clinical Programs in Oncologyprnewswire.com · Jan 2021

Frequently asked questions

What does IO Biotech do?
IOBiotech appears to be a biotech company focused on oncology, with a founder who has extensive experience in cancer drug development and clinical advancement from roles at Roche, Eli Lilly, and leading academic cancer centers.
Who are IO Biotech's investors?
IO Biotech's investors include Avoro Capital Advisors, EIR Ventures, Kurma Partners, Pivotal Life Sciences, RA Capital, Samsara BioCapital, Sunstone Capital, Vivo Capital and 2 more.